Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.14%189.48B | -2.08%801.75B | -9.66%183.71B | -6.54%818.76B | -11.48%210.78B | -11.24%207.31B | -10.32%197.32B | 10.29%203.35B | 14.83%876.08B | 16.54%238.11B |
| Cost of revenue | 6.14%106.37B | -5.86%444.61B | -11.15%100.22B | -2.05%472.3B | -6.50%122.49B | -5.49%121.17B | -2.70%115.84B | 8.53%112.8B | 15.89%482.2B | 15.04%131B |
| Gross profit | -0.47%83.1B | 3.08%357.14B | -7.79%83.49B | -12.04%346.46B | -17.57%88.29B | -18.23%86.14B | -19.31%81.49B | 12.56%90.55B | 13.57%393.88B | 18.42%107.11B |
| Operating expense | -3.17%74.01B | -3.58%300.36B | 6.17%76.43B | 5.43%311.51B | 6.87%84.81B | 8.23%79.66B | 1.75%75.05B | 4.71%71.99B | 13.59%295.47B | 17.63%79.36B |
| Selling and administrative expenses | -2.85%64.25B | -1.23%258.77B | 4.97%66.14B | 7.80%261.98B | 4.31%68.27B | 9.97%67.71B | 6.42%62.99B | 10.91%63B | 13.97%243.02B | 15.29%65.45B |
| -General and administrative expense | -2.85%64.25B | -1.23%258.77B | 4.97%66.14B | 7.80%261.98B | 4.31%68.27B | 9.97%67.71B | 6.42%62.99B | 10.91%63B | 13.97%243.02B | 15.29%65.45B |
| Research and development costs | 12.51%12.48B | -11.58%44.34B | -16.27%11.09B | -0.08%50.14B | -11.41%12.25B | -0.22%12.5B | 0.26%12.15B | 13.11%13.25B | 13.34%50.18B | 23.24%13.83B |
| Other operating expenses | -242.50%-2.72B | -349.10%-2.74B | 81.37%-793M | -126.83%-611M | 5,002.38%4.29B | -10.58%-554M | -103.50%-86M | -1,896.20%-4.26B | -12.49%2.28B | 116.00%84M |
| Operating profit | 28.78%9.09B | 62.45%56.78B | -61.96%7.06B | -64.48%34.95B | -87.44%3.48B | -79.60%6.48B | -76.37%6.43B | 58.67%18.56B | 13.49%98.41B | 20.73%27.75B |
| Net non-operating interest income (expenses) | ||||||||||
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 98.02%-388M | -27.78B | -19.56B | 0 | ||||||
| Less:Restructuring and mergern&acquisition | -98.02%388M | --27.78B | --19.56B | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 169.62%8.7B | -17.03%29B | -167.36%-12.5B | -64.48%34.95B | -87.44%3.48B | -79.60%6.48B | -76.37%6.43B | 58.67%18.56B | 13.49%98.41B | 20.73%27.75B |
| Income tax | 154.04%1.46B | 28.27%13.45B | -160.95%-2.7B | -57.96%10.49B | -78.31%1.27B | -77.53%1.96B | -61.85%2.83B | 50.80%4.42B | 8.23%24.94B | -0.64%5.87B |
| Net income | 176.82%7.19B | 49.49%14.87B | -168.93%-9.36B | -86.65%9.95B | -95.45%1.07B | -89.50%2.41B | -135.40%-7.1B | 67.81%13.58B | 20.15%74.55B | 40.60%23.43B |
| Net income continuous operations | 176.82%7.19B | 49.49%14.87B | -168.93%-9.36B | -86.65%9.95B | -95.45%1.07B | -89.50%2.41B | -135.40%-7.1B | 67.81%13.58B | 20.15%74.55B | 40.60%23.43B |
| Noncontrolling interests | 39.18%373M | -175.81%-1.4B | 48.89%268M | 169.59%1.84B | 900.00%810M | 99.38%642M | 29.27%212M | 53.85%180M | 6.21%684M | 6.58%81M |
| Net income attributable to the company | 170.81%6.82B | 100.75%16.27B | -171.86%-9.63B | -89.03%8.11B | -98.90%256M | -92.19%1.77B | -136.76%-7.32B | 68.02%13.4B | 20.29%73.86B | 40.75%23.34B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 170.81%6.82B | 100.75%16.27B | -171.86%-9.63B | -89.03%8.11B | -98.90%256M | -92.19%1.77B | -136.76%-7.32B | 68.02%13.4B | 20.29%73.86B | 40.75%23.34B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 170.81%34.62 | 100.70%82.63 | -171.84%-48.89 | -88.94%41.17 | -98.90%1.3 | -92.14%8.98 | -137.23%-37.16 | 70.21%68.05 | 21.77%372.19 | 42.26%118.25 |
| Diluted earnings per share | 170.81%34.62 | 100.70%82.63 | -171.84%-48.89 | -88.94%41.17 | -98.90%1.3 | -92.14%8.98 | -137.23%-37.16 | 70.21%68.05 | 21.77%372.19 | 42.25%118.2409 |
| Dividend per share | 0 | 0.00%104 | 0 | 6.12%104 | 6.12%52 | 0 | 6.12%52 | 0 | 6.52%98 | 6.52%49 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |